A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease

BACKGROUND: The quantification of amyloid-beta (Aβ) peptides in blood plasma as potential biomarkers of Alzheimer’s disease (AD) is hampered by very low Aβ concentrations and the presence of matrix components that may interfere with the measurements. METHODS: We developed a two-step immunoassay for...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahpasand-Kroner, Hedieh, Klafki, Hans-W., Bauer, Chris, Schuchhardt, Johannes, Hüttenrauch, Melanie, Stazi, Martina, Bouter, Caroline, Wirths, Oliver, Vogelgsang, Jonathan, Wiltfang, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286509/
https://www.ncbi.nlm.nih.gov/pubmed/30526652
http://dx.doi.org/10.1186/s13195-018-0448-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286509/
https://www.ncbi.nlm.nih.gov/pubmed/30526652
http://dx.doi.org/10.1186/s13195-018-0448-x

Ejemplares similares